We hypothesized that both global knockout and conditional knockout of Ripk2 in microglia would prove beneficial in reducing acute-stage neuroinflammation and preserving BBB integrity, as well as improving behavioral outcomes in these animals after stroke. This evidence concerns the gene RIPK2 and stroke disorder.